Shilpa Medicare Ltd Share Price – NSE  / BSE

Pharmaceuticals, Small Cap

Shilpa Medicare announced that the Board of Directors of the Company at its meeting held on 22 May 2026, inter alia, have recommended the final dividend of Rs 0.6 per equity Share (i.e. 60%) , subject to the approval of the shareholders.

Net profit of Shilpa Medicare rose 642.87% to Rs 107.79 crore in the quarter ended March 2026 as against Rs 14.51 crore during the previous quarter ended March 2025. Sales rose 32.09% to Rs 436.99 crore in the quarter ended March 2026 as against Rs 330.82 crore during the previous quarter ended March 2025.

For the full year,net profit rose 210.81% to Rs 243.33 crore in the year ended March 2026 as against Rs 78.29 crore during the previous year ended March 2025. Sales rose 19.62% to Rs 1538.87 crore in the year ended March 2026 as against Rs 1286.43 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 22 May 2026.

Shilpa Medicare has appointed Dr. Vellaian Karuppiah has been appointed as the Chief Operating Officer (COO) - Formulations (Senior Managerial Personnel) of the Company with effect from 23 April 2026.